Pattern hair loss is hair loss that primarily affects the top and front of the scalp. In male-pattern hair loss, the hair loss typically presents itself as either a receding front hairline, loss of hair on the crown (vertex) of the scalp, or a combination of both. Female-pattern hair loss typically presents as a diffuse thinning of the hair across the entire scalp.
☆ AI Dermatology — Free Service Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation.
Ukulahleka kwezinwele okuyiphethini yabesilisa kubonakala kubangelwa inhlanganisela yofuzo nama‑androgens ajikelezayo, ikakhulukazi i‑dihydrotestosterone (DHT). Isizathu sokuqothuka kwezinwele okuyiphethini yabesifazane asikacaci.
Ukwelashwa okuvamile kubandakanya i‑minoxidil, i‑finasteride, i‑dutasteride, noma ukuhlinzwa kokufakelwa izinwele. Ukusetshenziswa kwe‑finasteride ne‑dutasteride kwabesifazane abakhulelwe kungaholela ekutheni kube nezinkinga zokuzalwa.
○ Ukwelashwa
I‑Finasteride ne‑dutasteride zisebenza kahle kakhulu kwabesilisa nakwabesifazane abangemuva kokushona kweminyaka yokushona kwama‑hormone (postmenopausal). I‑minoxidil yomlomo enedosi ephansi ingasetshenziswa ezimeni ezikhethiwe ezithile.
#Finasteride
#Dutasteride
○ Ukwelashwa – Izidakamizwa ze‑OTC
Emazweni amaningi, ama‑formulation e‑topical minoxidil atholakala ngaphandle kokukhokha eshalofini (over‑the‑counter). Kukhona ezinye izithasiselo ezithi ziyasebenza ekulweni nokuqothuka kwezinwele, kodwa eziningi azikafakazelwa ngokwesayensi ukuthi ziyasebenza.
#5% minoxidil